Abstract
We present the updated British Association for Sexual Health and HIV guideline for the management of non-gonococcal urethritis in men. This document includes a review of the current literature on its aetiology, diagnosis and management. In particular it highlights the emerging evidence that azithromycin 1 g may result in the development of antimicrobial resistance in Mycoplasma genitalium and that neither azithromycin 1 g nor doxycycline 100 mg twice daily for seven days achieves a cure rate of >90% for this micro-organism. Evidence-based diagnostic and management strategies for men presenting with symptoms suggestive of urethritis, those confirmed to have non-gonococcal urethritis and those with persistent symptoms following first-line treatment are detailed.
| Original language | English |
|---|---|
| Pages (from-to) | 85-96 |
| Number of pages | 12 |
| Journal | International Journal of STD and AIDS |
| Volume | 27 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2016 |
Keywords
- Anti-Bacterial Agents
- Azithromycin
- Chlamydia Infections
- Chlamydia trachomatis
- Disease Management
- Doxycycline
- Drug Resistance, Bacterial
- Fluoroquinolones
- Great Britain
- Humans
- Male
- Metronidazole
- Mycoplasma Infections
- Mycoplasma genitalium
- Practice Guidelines as Topic
- Urethritis
